Chronic Myeloproliferative Disorders Completed Phase 3 Trials for Nystatin (DB00646)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002742Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic CancerSupportive Care